B.More
  • Why Psilocybin?
  • Resources
  • About Us
  • PR & News
  • Clinical Trials
  • Get Involved
Select Page

B.More Advances FDA Drug Trials using Psilocybin to Treat Alcoholism

by bmore-dev | Jul 20, 2021 | Uncategorized

FDA Drug Trials of Psilocybin to Treat Alcoholism by B.More Show Promising Results B.More Advances FDA Drug Trials using Psilocybin to Treat Alcoholism B.More is pursuing groundbreaking clinical trials to treat alcoholism with psilocybin. Psilocybin appears to produce...

Recent Posts

  • B.More Advances FDA Drug Trials using Psilocybin to Treat Alcoholism

Recent Comments

    Stay informed of B. More news and research:

    BMORE-LOGO-STACKED-WHITE
    hello@bmoreinc.org
    Get Involved

    • Follow
    • Follow
    • Follow

    B.More is a 501(c)(3) non-profit lifescience company studying psilocybin, a classic psychedelic, to treat patients suffering from Alcohol Use Disorder (AUD) and who may have been unsuccessful with more traditional drugs and treatments.

    © 2020-2023 B.More. Privacy Policy | Terms of Service

    All rights reserved.